Introduction to the Department

The Hematology & Medical Oncology Division of the Internal Medicine Department consists of the area of internal medicine for hematology, which deals with multiple myeloma, malignant lymphoma, acute and chronic leukemia, anemia, cytopenia, and thrombosis/coagulation disorders, and the area of internal medicine for solid tumors, which covers the systemic treatment of solid cancers such as stomach cancer, lung cancer, colon cancer, head and neck cancer, breast cancer, pancreatic & biliary tract cancer, urinary tract cancer, osteosarcoma, soft-tissue sarcoma, and gynecological cancer. Our division coordinates the diagnosis and treatment of hematologic and oncologic diseases and is in charge of chemotherapy, biologic therapy, and hematopoietic stem cell transplantation. If surgery or radiation therapy is required, we work in close cooperation with the related Surgery Department, Radiation Oncology Department, and various subdepartments of the Internal Medicine Department to deliver optimal care to our patients.

Inpatient wards for Hematology & Medical oncology

These are wards 96, 105, and 106. Five-person rooms are operated as short-term admission units exclusively for patients receiving chemotherapy, thereby providing patients who need repeated chemotherapy and intensive care to receive anticancer therapy in a comfortable environment while minimizing their economic burden. In addition, ward 106 is a special-care unit for bone marrow transplantation, including isolated rooms for immunocompromised patients. Hematopoietic stem cell transplantation has been successfully performed for the treatment of leukemia, multiple myeloma, malignant lymphoma, myelodysplastic syndrome, myeloproliferative disorder, and aplastic anemia.

Infusion Room for Hematology & Medical Oncology (Day Ward)

This is located on the 5th floor of the New Cancer Hospital. By operating an independent space for patients receiving chemotherapy, more specialized and efficient treatments are enabled while allowing the patients to receive anticancer therapy in a comfortable environment and minimizing their economic burden.

Clinical trial and basic research

Many clinical trials related with novel agents, including early-phase clinical trials, are conducted in our division. Basic researches related with drug sensitivity and novel agents are also in progress. There is a Clinical Trial Center for clinical trials and a laboratory for basic research. Many clinical-research nurses and laboratory researchers are contributing to the studies.

Education

There are education programs for patients, medical students, and visiting doctors. An education lecture for the general public is held annually. An education book for patients receiving chemotherapy was recently published, offering detailed information on how to cope with cancer and cancer treatment. An international visiting scholar program has also been established.